Medini Rastogi
Clinical Research Coordinator
HDF Comprehensive Cancer Ctr
School of Medicine

Publications (1)

Top publication keywords:
Prostate-Specific AntigenHumansTreatment OutcomeHeterocyclic Compounds, 1-RingMaleProstatic Neoplasms, Castration-Resistant

• Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial.
  The Lancet. Oncology 2023 Aggarwal R, Starzinski S, de Kouchkovsky I, Koshkin V, Bose R, Chou J, Desai A, Kwon D, Kaushal S, Trihy L, Rastogi M, Ippisch R, Aslam M, Friedlander T, Feng F, Oh D, Cheung A, Small E, Evans M, Fong…